Schedule 13D ownership disclosure
Atea Pharmaceuticals Inc
Security class unavailable · CUSIP: 04683R106
Event date: 2020-11-03
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-291677
- Form type
- SC 13D
- Filer
- Atea Pharmaceuticals, Inc.
- CIK
- CIK 1593899
- Filed
- Nov 12, 2020
- Reporting period
- Nov 03, 2020
- Description
- Schedule 13D beneficial ownership